Member Exclusive

Japanese Pharmaceutical & Medical Devices Agency

As part of its Japanese partnering strategy, RepliCel seeks advice of Japanese regulators around its fibroblast platform

Go to the profile of Lee Buckler
Mar 23, 2015
0
0

Please sign in or register for FREE

No comments yet.